NAACCR Item #3922: Response to Neoadjuvant Therapy
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3922 | 1 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | responseToNeoadjuvantTherapy | Tumor |
Required Status:
NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Collected by SEER from CoC-accredited hospitals
CCCR Collect: No recommendation
Description
This data item records the physician's statement of response to neoadjuvant chemotherapy.
Rationale
Response to Neoadjuvant Therapy is a Registry Data Collection Variable in AJCC. It was previously collected as Breast, CS SSF #21.
Allowable Values
0-4, 8, 9
Codes
| Code | Description |
|---|---|
| 0 | Neoadjuvant therapy not given |
| 1 | Stated as complete response (CR) |
| 2 | Stated as partial response (PR) |
| 3 | Stated as response to treatment, but not noted if complete or partial |
| 4 | Stated as no response (NR) |
| 8 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error.) |
| 9 | Not documented in medical record Response to neoadjuvant therapy not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.